Symbol="AVIR"
AssetType="Common Stock"
Name="Atea PharmaceuticalsÂ Inc"
Description="Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapies for patients suffering from viral infections. The company is headquartered in Boston, Massachusetts."
CIK="1593899"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="125 SUMMER STREET, 16TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="282724000"
EBITDA="-132566000"
PERatio="None"
PEGRatio="None"
BookValue="7.22"
DividendPerShare="0"
DividendYield="0"
EPS="-1.23"
RevenuePerShareTTM="2.31"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.126"
ReturnOnEquityTTM="-0.168"
RevenueTTM="192180000"
GrossProfitTTM="-81936000"
DilutedEPSTTM="-1.23"
QuarterlyEarningsGrowthYOY="2.641"
QuarterlyRevenueGrowthYOY="2.952"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.903"
PriceToBookRatio="0.551"
EVToRevenue="58.97"
EVToEBITDA="-9.68"
Beta="0.176"
num_52WeekHigh="8.3"
num_52WeekLow="2.94"
num_50DayMovingAverage="3.699"
num_200DayMovingAverage="4.045"
SharesOutstanding="83399000"
DividendDate="None"
ExDividendDate="None"
symbol="AVIR"
open="3.36"
high="3.42"
low="3.28"
price="3.34"
volume="583963.00"
latest_trading_day="2023-08-18"
previous_close="3.40"
change="-0.06"
change_percent="-1.7647%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="44"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="56"
Volume_recent_avg="587682"
Change_recent_avg="-0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="56"
Aroon_momentum_negative="44"
image_negative_thumbnail_id_1="1120"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_negative_thumbnail_id_2="1151"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0184.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="951"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_positive_thumbnail_id_2="626"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0082.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
